Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.63 CAD | 0.00% | 0.00% | -3.08% |
Mar. 21 | LifeSpeak Inc. Reports Q4 2023 Adjusted Loss of $0.05 Per Share | MT |
Mar. 21 | Transcript : LifeSpeak Inc., Q4 2023 Earnings Call, Mar 21, 2024 |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Capitalization 1 | 306.7 | 48.43 | 33.09 | 37.26 | - |
Enterprise Value (EV) 1 | 290.6 | 131.5 | 33.09 | 111.1 | 102.6 |
P/E ratio | -8.36 x | -1 x | -1.25 x | -2.2 x | -2.8 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | 13.2 x | 1.02 x | 0.63 x | 0.7 x | 0.62 x |
EV / Revenue | 12.5 x | 2.78 x | 0.63 x | 2.1 x | 1.71 x |
EV / EBITDA | 44.1 x | 15.1 x | 2.55 x | 8.69 x | 5.98 x |
EV / FCF | -25.4 x | -16.8 x | - | -278 x | 19 x |
FCF Yield | -3.94% | -5.96% | - | -0.36% | 5.27% |
Price to Book | - | - | - | - | - |
Nbr of stocks (in thousands) | 48,303 | 50,982 | 50,911 | 59,136 | - |
Reference price 2 | 6.350 | 0.9500 | 0.6500 | 0.6300 | 0.6300 |
Announcement Date | 3/22/22 | 3/31/23 | 3/21/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net sales 1 | - | 23.27 | 47.37 | 52.41 | 52.9 | 59.89 |
EBITDA 1 | - | 6.594 | 8.688 | 12.98 | 12.79 | 17.15 |
EBIT 1 | - | -6.605 | -15.67 | -11.68 | -5.914 | -1.964 |
Operating Margin | - | -28.39% | -33.08% | -22.28% | -11.18% | -3.28% |
Earnings before Tax (EBT) 1 | - | -27.24 | -51.35 | -31.21 | -17.69 | -13.86 |
Net income 1 | 0.0978 | -26.32 | -47.91 | -26.26 | -16.81 | -13.41 |
Net margin | - | -113.14% | -101.15% | -50.11% | -31.78% | -22.39% |
EPS 2 | - | -0.7600 | -0.9500 | -0.5200 | -0.2867 | -0.2250 |
Free Cash Flow 1 | - | -11.45 | -7.839 | - | -0.4 | 5.4 |
FCF margin | - | -49.23% | -16.55% | - | -0.76% | 9.02% |
FCF Conversion (EBITDA) | - | - | - | - | - | 31.48% |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 6/14/21 | 3/22/22 | 3/31/23 | 3/21/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 5.921 | 6.838 | 8.71 | 12.14 | 12.77 | 13.76 | 13.4 | 13.16 | 12.9 | 12.95 | 12.85 | 13.07 | 13.37 | 13.64 | 14.05 |
EBITDA 1 | 1.561 | 0.941 | 0.382 | 2.412 | 3.078 | 4.816 | 3.682 | 3.336 | 3.251 | 2.717 | 2.931 | 3.021 | 3.337 | 3.362 | 3.7 |
EBIT 1 | -3.216 | -5.24 | -8.142 | -5.43 | 0.464 | -0.563 | -2.604 | -5.046 | -0.123 | -3.903 | -1.816 | -1.652 | -1.346 | -1.099 | - |
Operating Margin | -54.32% | -76.63% | -93.48% | -44.73% | 3.63% | -4.09% | -19.44% | -38.33% | -0.95% | -30.14% | -14.14% | -12.63% | -10.07% | -8.06% | - |
Earnings before Tax (EBT) 1 | -20.08 | -7.764 | -17.46 | -6.986 | -1.81 | -25.93 | -1.249 | -7.528 | -2.674 | -19.76 | -4.741 | -4.597 | -4.194 | -4.195 | -3.4 |
Net income 1 | -20.08 | -6.846 | -16.35 | -6.457 | -1.406 | -24.54 | -0.354 | -6.251 | -1.982 | -17.68 | -4.507 | -4.367 | -3.967 | -3.972 | -3.1 |
Net margin | -339.06% | -100.12% | -187.76% | -53.19% | -11.01% | -178.43% | -2.64% | -47.49% | -15.37% | -136.5% | -35.07% | -33.4% | -29.67% | -29.13% | -22.06% |
EPS 2 | -0.4300 | -0.1100 | -0.3330 | -0.1300 | -0.0300 | -0.5300 | -0.0100 | -0.1200 | -0.0390 | -0.3500 | -0.0833 | -0.0733 | -0.0633 | -0.0667 | -0.0500 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/10/21 | 3/22/22 | 5/12/22 | 8/3/22 | 11/10/22 | 3/31/23 | 5/15/23 | 8/9/23 | 11/8/23 | 3/21/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | 83.1 | - | 73.9 | 65.3 |
Net Cash position 1 | - | 16.1 | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | 9.564 x | - | 5.775 x | 3.807 x |
Free Cash Flow 1 | - | -11.5 | -7.84 | - | -0.4 | 5.4 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - |
Capex | - | 0.11 | - | - | - | - |
Capex / Sales | - | 0.49% | - | - | - | - |
Announcement Date | 6/14/21 | 3/22/22 | 3/31/23 | 3/21/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.08% | 27.22M | |
+11.17% | 322B | |
+24.75% | 216B | |
+2.41% | 149B | |
+10.65% | 56.27B | |
+8.71% | 32.13B | |
-4.57% | 27.45B | |
+103.03% | 22.62B | |
+20.22% | 19.55B | |
+13.06% | 14.69B |
- Stock Market
- Equities
- LSPK Stock
- Financials LifeSpeak Inc.